Gold falls to 4-month low as stocks jump on strong U.S. data

By Shreyansi Singh (Reuters) - Gold fell nearly 2% to its lowest in four-months on Monday as better-than-expected U.S. business activity data and optimism over progress in COVID-19 vaccines boosted hopes for a swifter economic rebound and drove investors towards riskier assets.

Reuters November 24, 2020 00:06:32 IST
Gold falls to 4-month low as stocks jump on strong U.S. data

Gold falls to 4month low as stocks jump on strong US data

By Shreyansi Singh

(Reuters) - Gold fell nearly 2% to its lowest in four-months on Monday as better-than-expected U.S. business activity data and optimism over progress in COVID-19 vaccines boosted hopes for a swifter economic rebound and drove investors towards riskier assets.

Spot gold dipped 1.8% to $1,836.71 per ounce by 10:29 a.m. EST (1529 GMT), after falling to its lowest since July 21 at $1,834.95. U.S. gold futures shed 2% to $1,834.80.

Stocks jumped after data showed U.S. business activity in November expanded at its fastest rate in more than five years, pointing to a recovery from the pandemic's economic damage.

"Gold broke below the key $1,850 level after an unbelievably strong U.S. PMI release just dampened the need for stimulus. No one was expecting such strong readings in both services and manufacturing," said Edward Moya, senior market analyst at OANDA.

The upbeat data came after Britain's AstraZeneca said its vaccine could be around 90% effective without any serious side effects.

Further denting bullion, the dollar rose against rivals, while the benchmark 10-year Treasury yield also jumped. [USD/][US/]

Gold's break below $1,850 triggered a wave of sell stops, said Phillip Streible, chief market strategist at Blue Line Futures in Chicago.

Gold, considered a hedge against inflation and currency debasement, has gained over 21% this year, mainly benefiting from the economic damage from the pandemic and the resultant global stimulus measures.

"While we do expect gold to go onto the defensive when the global economies start to show sustainable recoveries, the tailwinds behind the market have not yet been fully dissipated," said StoneX analyst Rhona O'Connell in a note.

Silver fell 2.6% to $23.52 an ounce, platinum dipped 1.5% to $932.15, while palladium rose 0.4% to $2,335.95.

(Reporting by Shreyansi Singh and Sumita Layek in Bengaluru)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Target holiday sales jump 17% as shoppers splurge online
Business

Target holiday sales jump 17% as shoppers splurge online

By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.

S&P 500, Nasdaq tick higher on Intel boost
Business

S&P 500, Nasdaq tick higher on Intel boost

By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses
Business

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses

By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.